Vertical

Healthcare

The job identity does in this industry

Healthcare identity is two distinct programs: clinician identity (workforce) and patient identity (CIAM, plus identity verification). Both intersect with strict access auditing under HIPAA.

Regulatory floor

HIPAA Security Rule requires access controls, audit logs, and integrity controls. The Breach Notification Rule means access logs are forensic evidence. HITECH increased enforcement. Outside the US, healthcare data falls under GDPR or local equivalents.

Use cases by segment

  • Hospital systems: EHR access via SSO, tap-and-go authentication at shared workstations, break-glass access during emergencies
  • Telehealth platforms: Patient identity verification, consent management, clinician credential validation
  • Payer / insurance: Member portal CIAM, agent workforce IAM, fraud detection
  • Pharma R&D: GxP-compliant access (21 CFR Part 11), researcher federation across institutions
  • HealthTech SaaS: B2B identity for hospital customers, fine-grained authorization across PHI

Vendor landscape

Workforce: Microsoft Entra and Okta dominate. Imprivata is the specialist for clinical workflows (tap-and-go badge auth at shared stations). SailPoint is the IGA reference for entitlement reviews. For patient identity, Auth0, Descope, and Stytch compete on CIAM developer experience. Persona and Onfido lead identity verification.

Common pitfalls

  • Treating clinician and patient identity as one program — they have fundamentally different requirements
  • Failing to design break-glass access that is auditable but not too friction-laden to use
  • Not federating with state-level health information exchanges
  • Underestimating MFA fatigue when clinicians touch 50+ systems per shift
  • Mistaking BAA coverage for end-to-end compliance

Outlook

Expect tighter coupling between identity verification and care delivery as telehealth matures. CMS interoperability rules push consent management into the identity stack. Passkey adoption for patient portals is the clear next step but will be slow due to demographic adoption curves.